Delivery Order SPE2DB20D1100-SPE2DB24FA4P8
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The delivery order, valued at $1,475.42, is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The delivery order has a ceiling value of $1,557.57 and a performance period through March 11, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this award. This delivery order is issued under an...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical sourcing and distribution services company. The $3,859.73 order is for fluticasone propionate HFA 110 mcg 12 gm inhalers, with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a prescription medication. The firm-fixed-price delivery order has a ceiling value of $5,892.99 and an ultimate completion date of August 23, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a potential value of $2,304.33 and a period of performance through February 23, 2024. No set-aside designation was used for this award....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,939.85 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. This delivery order contract has a performance period through January 29, 2024 and does not contain any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM. The contract has a potential value of $1,234.00 and a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract, valued at $1,619.26, is for the provision of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $3,918.52 and a period of performance through January 3, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds...
- This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $2,256.02 and a period of performance through May 16, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4P8Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a potential value of $5,492.40 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an Indefinite Delivery Contract (IDC) that it holds with DLA. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025, serving as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this delivery order or the underlying IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 2/28/24 |